• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol-South Tyrol-Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Long-lived oxidants in innate immunity

Long-lived oxidants in innate immunity

Markus Nagl (ORCID: 0000-0002-1225-9349)
  • Grant DOI 10.55776/P15240
  • Funding program Principal Investigator Projects
  • Status ended
  • Start December 1, 2001
  • End June 30, 2004
  • Funding amount € 87,230

Disciplines

Health Sciences (20%); Medical-Theoretical Sciences, Pharmacy (80%)

Keywords

    INNATE IMMUNITY, INTRACELLULAR KILLING, LONG-LIVED OXIDANTS, CATIONIC PROTEINS, COMPLEMENT, N-CHLOROTARINE

Abstract Final report

Phagocytosis and intracellular killing of invading pathogens by human granulocytes is a major feature of the innate immune system to overcome infection. When bacteria are engulfed into phagocytic vacuoles, they are attacked by a number of oxidative molecules formed by an enzymatic cascade. While highly reactive oxidants are consumed within seconds in vivo, stable N-chloro compounds (chloramines, R-NHCl) are in contact with the target pathogens for extended time periods. Recently, low molecular weight representatives (i.e. N-chloro amino acids) of these long-lived oxidants (LLO) have been shown to possess microbicidal activity. They are considered to contribute to destruction of bacteria during infection and, moreover, they seem to be of advantage as new antimicrobial agents in topical therapy of infections. The first aim of this project is to clarify the interaction of selected LLO with bacteria and fungi. Surface attack on cell walls and membranes and penetration of LLO into the microbial cytosol will be investigated using spectrophotometric and functional tests, 2D electrophoresis and mass spectrometry of possible target proteins as well as radiolabelling of targets and LLO. Pathogens exposed to LLO for a sublethal period of time are known to lose virulence in an in-vivo model as a first step of inactivation. Phagocytosis and intracellular killing of these attenuated micro-organisms will be addressed. The second aim is to investigate the combined effect of LLO and non-oxidative antimicrobial agents of granulocytes against bacteria and fungi. These agents are cationic proteins (defensins, bactericidal-permeability increasing protein, cathepsin G, lysozyme ...) deposited within the leukocyte granules which attack mainly the surface of pathogens and will act at least in part simultaneously with LLO in vivo. Experiments on the simultaneous impact of LLO and the most important non-oxidants on bacterial and fungal viability will be performed. As a third aim, the effect of LLO on the biology and function of cationic proteins will be monitored by protein electrophoresis, mass spectrometry and functional tests. The fourth aim is to investigate the interaction of LLO with the key components of the complement system, an important plasma-protein based defence system linked with cellular effectors like granulocytes. The results of this project will contribute essentially to the understanding of the action and co-operation of granulocyte antimicrobial agents in eradication of pathogens. In addition, valuable knowledge for application of synthetically generated LLO in human medicine will be gained. The project matches the recently established program of central interest ("Schwerpunktprogramm der Medizinischen Fakultät") on "Infection - immunity and pathogens" of the Medical Faculty at the University of Innsbruck.

N-chlorotaurine (NCT), one of the most important long-lived oxidants produced by the human body to overcome infections, has been synthetized and made available as pure substance in our laboratory. Since it exerts broad- spectrum killing activity against pathogens, the results of our science are important for both its natural role in the human body to inactivate bacteria, fungi, and viruses and for its topical application as aqueous solution to treat infections in human medicine. In this project a number of results have been obtained regarding the chemistry and the mechanism of action of NCT. Its chemical properties (such as determination of purity, stability, storage conditions, chemical reactions) have been thoroughly investigated, which is an obligatory basis for clinical application. NCT can be prepared at 99% purity and stored at 2-4C for one year without the occurrence of noxious decay products. For a therapy cycle, storage at room temperature is sufficient. The chemical reactions of NCT in a therapeutically applied concentration are harmful only to the pathogens invading the body but not to human tissue, as proven repeatedly in clinical studies. The first interaction with bacteria and fungi is oxidation of their surface leading to inhibition of growth and loss of virulence which means that they cannot cause severe infections any more. A very short incubation time of 1 min is sufficient for these effects, which may explain the efficacy of NCT applied for instance as eye drops, where relatively short contact times are warranted that do not necessarily lead to complete killing of the pathogens. Clinical studies within the project proved the tolerability and efficacy of NCT in infected leg ulcers, in the infected outer ear canal. There are also strong hints for efficacy in chronic rhinosinusitis and severe viral eye infections, both of which are in part lacking causative therapy up to date.

Research institution(s)
  • Medizinische Universität Innsbruck - 100%

Research Output

  • 292 Citations
  • 6 Publications
Publications
  • 2005
    Title Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via yamik catheter
    DOI 10.1016/j.anl.2005.05.006
    Type Journal Article
    Author Neher A
    Journal Auris Nasus Larynx
    Pages 359-364
  • 2005
    Title Chlorine covers on living bacteria: the initial step in antimicrobial action of active chlorine compounds
    DOI 10.1093/jac/dki054
    Type Journal Article
    Author Gottardi W
    Journal Journal of Antimicrobial Chemotherapy
    Pages 475-482
    Link Publication
  • 2004
    Title Down-regulatory effect of N-chlorotaurine on tryptophan degradation and neopterin production in human PBMC
    DOI 10.1016/j.imlet.2004.03.006
    Type Journal Article
    Author Wirleitner B
    Journal Immunology Letters
    Pages 143-149
  • 2003
    Title Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study
    DOI 10.1046/j.1365-2133.2003.05432.x
    Type Journal Article
    Author Nagl M
    Journal British Journal of Dermatology
    Pages 590-597
  • 2002
    Title Impact of N-Chlorotaurine on Viability and Production of Secreted Aspartyl Proteinases of Candida spp
    DOI 10.1128/aac.46.6.1996-1999.2002
    Type Journal Article
    Author Nagl M
    Journal Antimicrobial Agents and Chemotherapy
    Pages 1996-1999
    Link Publication
  • 2002
    Title Phagocytosis and Killing of Bacteria by Professional Phagocytes and Dendritic Cells
    DOI 10.1128/cdli.9.6.1165-1168.2002
    Type Journal Article
    Author Nagl M
    Journal Clinical and Diagnostic Laboratory Immunology
    Pages 1165-1168
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF